Stuart M Sprague is an expert in Nephrology at University of Chicago (United States). As of June 2026, ScienceLeadR ranks Stuart M Sprague in the top 1% of experts worldwide for Parathyroid Diseases. Stuart M Sprague has authored 217 publications, the most recent in 2026, and is an investigator in 6 clinical trials. SLR score: 704 (community average: 125). How the SLR is computed.

LeadR Profile

Stuart M Sprague University of Chicago United States
704 ScienceLeadR Reputation 704
Network Map

Nephrology

Subspecialties: Endocrinology - Urology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2026

Source: PubMed

University of Chicago

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 217

Citations

Citations: 8 100 1st author: 42 Last author: 81 Unique author: 15


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial.
PMID 42166177 — hypoparathyroidism, safety, serum, calcium, therapeutics
J Bone Miner Res20260
Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
PMID 41996191 — kidney, maintenance, therapeutics, hyperphosphatemia
Kidney36020260
Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?
PMID 40857105 — vitamin d, vitamins, kidney
Kidney36020250
A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients.
PMID 40485682 — phosphate transport proteins
Kidney Int Rep20250
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial.
PMID 40466630 — kidney diseases, pilots, serum, vitamins, kidney, hormones, nephrology, calcium, therapeutics, calcifediol, hyperparathyroidism, hyperparathyroidism, secondary
Am J Nephrol20257

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 2
Phase 3 2
N/A 1
Phase 4 1

By status:

Completed 6

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 2
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map